Latest News and Press Releases

Pneumagen’s intranasal broad-spectrum antiviral therapy reduced infection, improved symptoms and severity and reduced viral load in a Phase II influenza study in data published in the high-impact,...

Translational Data Presented at EACCI Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor

Upstream Bio to Present Mechanistic Insights into Verekitug’s Enhanced Potency via TSLP Receptor Targeting at EACCI 2025

Dublin, May 29, 2025 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease: 68-Market Analysis and Sales Forecast - Update" has been added to ResearchAndMarkets.com's offering. The...

Upstream Bio Appoints Stacy Price as Chief Technology Officer

Upstream Bio Reports First Quarter 2025 Financial Results and Accelerates Guidance on All Clinical Programs

24 abstracts, including 1 oral presentation and 4 late-breaking posters on Dupixent, to showcase new clinical and real-world analyses in chronic obstructive pulmonary disease (COPD) and asthma COPD...

Ottawa, April 08, 2025 (GLOBE NEWSWIRE) -- The global chronic obstructive pulmonary disease market size was valued at USD 22.55 billion in 2024 and is predicted to hit around USD 33.29 billion by...

Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils Approval marks the first new treatment approach for...

NEW HAVEN, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Wellinks, a digital healthcare company specializing in Chronic Obstructive Pulmonary Disease (COPD) management, today announced a strategic...